Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Study to Compare Vascular Healing After Deployment of the Abluminal Sirolimus Coated Bio-Engineered (Combo) Stent Versus the Everolimus Eluting Stent in Patients With Acute Coronary Syndrome by Means of OCT

NCT01405287 is registered in ClinicalTrials.gov with OrbusNeich as lead sponsor.

NCT NCT01405287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01405287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Study to Compare Vascular Healing After Deployment of the Abluminal Sirolimus Coated Bio-Engineered (Combo) Stent Versus the Everolimus Eluting Stent in Patients With Acute Coronary Syndrome by Means of OCT
Lead sponsor
OrbusNeich
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2011
Completion date
January 31, 2014
Enrollment
60 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome (acs), atherosclerosis, coronary artery disease, myocardial infarction (mi)